Schedule 13G ownership disclosure

Therapeutics Acquisition Corp.

Security class unavailable · CUSIP: 88339T103

Event date: 2020-07-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-195484
Form type
SC 13G
Filer
Bain Capital Life Sciences Fund II, L.P.
CIK
CIK 1773187
Filed
Jul 20, 2020
Reporting period
Jul 10, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub